SARS-CoV-2-IN-46

SARS-CoV-2-IN-46

• UNSPSC Description: SARS-CoV-2-IN-46 is a novel coronavirus (SARS-CoV-2) replication inhibitor with an EC50 of 0.9 μM in Calu-3 cells. SARS-CoV-2-IN-46 has antiviral activity and can be used in novel coronavirus (COVID-19) research[1].
• Target Antigen: SARS-CoV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-in-46.html
• Solubility: DMSO : 50 mg/mL (ultrasonic)
• Smiles: O=C1C2=CC=C(OC(F)F)C=C2O/C1=C\C3=CC=C(OC)C=C3
• Molecular Weight: 318.27
• References & Citations: [1]Caleffi GS, et al. Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication. J Nat Prod. 2023 Jun 23;86(6):1536-1549.
• Shipping Conditions: Room Temperature
• Clinical Information: No Development Reported